Thermo Fisher Q2 revenue beats estimates amid strong customer activity

Overview

• Lab equipment supplier's Q2 revenue grew 10%, beating analyst expectations

• Adjusted EPS for Q2 rose 13% and beat analyst expectations

• Company repurchased $1 bln of stock during the quarter

Outlook

• Company says it will provide updated 2026 financial guidance during its earnings conference call

Result Drivers

• NEW PRODUCT LAUNCHES - Co said revenue growth was supported by the launch of new products, including next-generation mass spectrometry platforms and PCR systems

• STRONGER END MARKETS - Co said customer activity across its end markets continued to strengthen, supporting revenue growth

• STRATEGIC COLLABORATIONS - Co said partnerships, such as with Precision Health Research Singapore, contributed to growth in precision medicine and biopharma services

Company press release: ID:nBwRh4W1a

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 26 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the advanced medical equipment technology peer group is "buy"

• Wall Street's median 12-month price target for Thermo Fisher Scientific Inc is $610.00, about 15.9% above its July 22 closing price of $526.46

• The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 20 three months ago

Reuters Recommended Reads

• July 21 - Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift

• July 23 - Sartorius beats half-year earnings expectations aided by tariff refunds

• July 22 - Teledyne lifts annual profit forecast, tops quarterly results estimates

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)